Hypoimmunogenic Human Pluripotent Stem Cells Are Valid Cell Sources for Cell Therapeutics with Normal Self-Renewal and Multilineage Differentiation Capacity
Scientists systematically studied the self-renewal and differentiation potency of three types of hypoimmunogenic hPSCs: B2Mnull, B2MmHLAG, and B2Mm/sHLAG.